Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura.
Völker LA, Kaufeld J, Balduin G, Merkel L, Kühne L, Eichenauer DA, Osterholt T, Hägele H, Kann M, Grundmann F, Kolbrink B, Schulte K, Gäckler A, Kribben A, Boss K, Potthoff SA, Rump LC, Schmidt T, Mühlfeld AS, Schulmann K, Hermann M, Gaedeke J, Sauerland K, Bramstedt J, Hinkel UP, Miesbach W, Bauer F, Westhoff TH, Bruck H, Buxhofer-Ausch V, Müller TJ, Wendt R, Harth A, Schreiber A, Seelow E, Tölle M, Gohlisch C, Bieringer M, Geuther G, Jabs WJ, Fischereder M, von Bergwelt-Baildon A, Schönermarck U, Knoebl P, Menne J, Brinkkoetter PT; German TTP-Study Group. Völker LA, et al. Among authors: von bergwelt baildon a. J Thromb Haemost. 2023 Mar;21(3):559-572. doi: 10.1016/j.jtha.2022.11.010. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696206 Free article.
Alternate-day dosing of caplacizumab for immune-mediated thrombotic thrombocytopenic purpura.
Kühne L, Kaufeld J, Völker LA, Wendt R, Schönermarck U, Hägele H, Osterholt T, Eichenauer DA, Bieringer M, von Bergwelt-Baildon A, Fischereder M, Buxhofer-Ausch V, Menne J, Brinkkoetter PT, Knöbl P. Kühne L, et al. Among authors: von bergwelt baildon a. J Thromb Haemost. 2022 Apr;20(4):951-960. doi: 10.1111/jth.15637. Epub 2022 Jan 23. J Thromb Haemost. 2022. PMID: 35000278 Free article.
SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
Floyd L, Elsayed ME, Seibt T, von Bergwelt-Baildon A, Seo P, Antiochos B, Kant S, Morris A, Dhaygude A, Schönermarck U, Geetha D. Floyd L, et al. Among authors: von bergwelt baildon a. Kidney Int Rep. 2022 Mar;7(3):629-632. doi: 10.1016/j.ekir.2021.12.004. Epub 2021 Dec 11. Kidney Int Rep. 2022. PMID: 34926870 Free PMC article. No abstract available.
Diminished Short- and Long-Term Antibody Response after SARS-CoV-2 Vaccination in Hemodialysis Patients.
Füessl L, Lau T, Lean I, Hasmann S, Riedl B, Arend FM, Sorodoc-Otto J, Soreth-Rieke D, Toepfer M, Rau S, Salihi-Halimi H, Paal M, Beuthien W, Thaller N, Suttmann Y, von Gersdorff G, Regenauer R, von Bergwelt-Baildon A, Teupser D, Bruegel M, Fischereder M, Schönermarck U. Füessl L, et al. Among authors: von bergwelt baildon a. Vaccines (Basel). 2022 Apr 13;10(4):605. doi: 10.3390/vaccines10040605. Vaccines (Basel). 2022. PMID: 35455353 Free PMC article.